Pathological Pathways and Alpha-Synuclein in Parkinson's Disease: A View from the Periphery.

alpha-synuclein autophagy inflammation microtubules mitochondria neurodegeneration synapses

Journal

Frontiers in bioscience (Landmark edition)
ISSN: 2768-6698
Titre abrégé: Front Biosci (Landmark Ed)
Pays: Singapore
ID NLM: 101612996

Informations de publication

Date de publication:
23 02 2023
Historique:
received: 20 12 2022
revised: 03 02 2023
accepted: 15 02 2023
entrez: 3 3 2023
pubmed: 4 3 2023
medline: 7 3 2023
Statut: ppublish

Résumé

Alpha-synuclein inclusions are the distinctive trait of brain areas affected by neurodegeneration in Parkinson's disease (PD). Nevertheless, PD is now considered as a multisystemic disorder, since alpha-synuclein pathology has been described also outside the central nervous system. In this regard, the early, non-motor autonomic symptoms point out an important role for the peripheral nervous system during disease progression. On this basis, we propose a review of the alpha-synuclein-related pathological processes observed at peripheral level in PD, starting from molecular mechanisms, through cellular processes to systemic modifications. We discuss their relevance in the etiopathogenesis of the disease, suggesting they are concurrent players in the development of PD, and that the periphery is an easily-accessible window to look at what is occurring in the central nervous system.

Identifiants

pubmed: 36866559
pii: S2768-6701(23)00798-0
doi: 10.31083/j.fbl2802033
doi:

Substances chimiques

alpha-Synuclein 0

Types de publication

Journal Article Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

33

Informations de copyright

© 2023 The Author(s). Published by IMR Press.

Déclaration de conflit d'intérêts

The authors declare no conflict of interest.

Auteurs

Milo Jarno Basellini (MJ)

Department of Biosciences, Università degli Studi di Milano, 20133 Milan, Italy.
Department of Biochemistry and Molecular Biology, Faculty of Biology, Universitat de Barcelona, 08028 Barcelona, Spain.

Josine Marie Kothuis (JM)

Department of Biosciences, Università degli Studi di Milano, 20133 Milan, Italy.

Alessandro Comincini (A)

Department of Biosciences, Università degli Studi di Milano, 20133 Milan, Italy.

Gianni Pezzoli (G)

Fondazione Grigioni per il Morbo di Parkinson, 20125 Milan, Italy.

Graziella Cappelletti (G)

Department of Biosciences, Università degli Studi di Milano, 20133 Milan, Italy.
Center of Excellence of Neurodegenerative Diseases, Università degli Studi di Milano, 20133 Milan, Italy.

Samanta Mazzetti (S)

Department of Biosciences, Università degli Studi di Milano, 20133 Milan, Italy.
Fondazione Grigioni per il Morbo di Parkinson, 20125 Milan, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH